
FDA Announces ‘Elsa’ AI Platform to Accelerate Drug Review and Safety Assessments
Prime Highlights: The FDA announced ‘Elsa,’ a generative AI platform that will help scientific reviewers and investigators simplify intricate workflows. Elsa improves efficiency in activities